Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening

Influenza A virus (IAV) infections cause major morbidity and mortality, generating an urgent need for novel antiviral therapeutics. We recently established a dual myxovirus high-throughput screening protocol that combines a fully replication-competent IAV-WSN strain and a respiratory syncytial virus...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Virol
Autori principali: Weisshaar, Marco, Cox, Robert, Morehouse, Zachary, Kumar Kyasa, Shiva, Yan, Dan, Oberacker, Phil, Mao, Shuli, Golden, Jennifer E., Lowen, Anice C., Natchus, Michael G., Plemper, Richard K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2016
Soggetti:
Vaccines and Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984618/
https://ncbi.nlm.nih.gov/pubmed/27252534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00898-16
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi